UDK: 616.12–008.46–002.2–085.224

Pharmacodynamics of betimil and riboxin in patients with chronic cardiac failure

N.A. Platonova

Кафедра клинической фармакологии и интенсивной терапии ВолГМУ

Abstract

Evidence-based approach has proved that inclusion of betimil into the treatment of patients with cardiac failure decreases the functional class of the disease more effectively than riboxin.

Keywords

heart failure, coronary disease, betimil, riboxin

Contacts